Target intelligence / Profile preview

Tryptophan synthase alpha subunit (trpA)

Target
trpA
Molecular classification
Enzyme, Lyase (specifically an aldolase), Alpha subunit of a heterotetrameric enzyme complex
01

Overview

Tryptophan synthase alpha subunit is the alpha component of the heterotetrameric enzyme tryptophan synthase, primarily found in bacteria, archaea, fungi, and plants but absent in animals[1][2]. It catalyzes the reversible aldol cleavage of indole-3-glycerol phosphate to yield indole and glyceraldehyde 3-phosphate; the indole is then passed via a hydrophobic channel to the beta subunit for subsequent condensation with serine to form L-tryptophan[1][2][4][7][8]. This organization enables substrate channeling and allosteric regulation between subunits. As it is essential for tryptophan biosynthesis in pathogens (including some infectious bacteria), it is investigated as a potential antimicrobial target, though no approved clinical inhibitors exist. The alpha subunit itself is recognized for its TIM barrel (α/β barrel) structure and critical role in enzyme catalytic efficiency and assembly[2][4][5][6].

Other names
Tryptophan synthase alpha chainTryptophan synthetase alpha subunittrpA (gene/protein abbreviation)Alpha-Tryptophan synthaseTSA1 (in plants)
02

Mechanism of action

Enzyme inhibition (competitive, allosteric, or active site inhibition) Disruption of substrate channeling or conformation changes

03

Biological functions

Amino acid biosynthesisTryptophan biosynthesis (final steps)Catalysis of indole and glyceraldehyde 3-phosphate formationSubstrate channeling (with beta subunit)
04

Disease associations

Infection (as a potential antimicrobial target in bacteria and pathogens)Other (no strong links to cancer, inflammation, or other human disease contexts)
05

Safety considerations

Specificity required for antimicrobial applications to avoid off-target effects in non-pathogenic bacteria; not present in humansResistance development in pathogen populations if used as antimicrobial target
06

Interacting drugs

No clinically used drugs directly target the alpha subunit; research inhibitors include substrate analogs and transition-state mimics (primarily used as biochemical tools)

1 more in the full profile.

07

Biomarkers

None established; not currently used as a clinical biomarker

Beyond the preview

Go deeper on Tryptophan synthase alpha subunit (trpA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tryptophan synthase alpha subunit (trpA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call